Back
HFA Premium Access

Inhibition of peripheral chemoreceptors improves ventilatory efficacy during exercise in heart failure with preserved ejection fraction

Session: Heart Failure ePosters - focus on Chronic Heart Failure 3
Topic: Pathophysiology
Speaker: Mrs K. Kulej-Lyko (Wroclaw, PL)
Event: Heart Failure 2022

Congress Presentation

Add to my library

Like

About the speaker

Mrs Katarzyna Kulej-Lyko

Wroclaw Medical University, Wroclaw (Poland)
0 follower

35 more presentations in this session

Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: A post-hoc analysis from the REWIND randomized trial

Speaker: Professor K. Branch (Seattle, US)

Access
Abstract
Slides
Like
Thumbnail

Prognostic value of pulse pressure in heart failure with preserved ejection fraction: findings from the RICA registry

Speaker: Doctor I. Bravo Candela (Sevilla, ES)

Access
Abstract
Slides
Like
Thumbnail

Repetitive ambulatory doses of levosimendan for patients as bridge to heart transplant. Findings from the LEVO-T registry.

Speaker: Doctor J. De Juan Baguda (Madrid, ES)

Access
Abstract
Slides
Like
Thumbnail

Sacubitril/valsartan use patterns among older adults with heart failure in routine care: a US population-based cohort study of >25,000 medicare beneficiaries

Speaker: Doctor A. Bhatt (Boston, US)

Access
Abstract
Slides
Like
Thumbnail

Efficacy of sodium glucose cotransporter-2 inhibitors for heart failure with preserved and with mildly reduced ejection fraction: a systematic review and meta-analysis

Speaker: Doctor R. Cordovez (Cebu City, PH)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Heart Failure ePosters - focus on Chronic Heart Failure 3

Speakers: Mrs K. Kulej-Lyko, Professor K. Branch, Doctor I. Bravo Candela, Doctor J. De Juan Baguda, Doctor A. Bhatt...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources